Back to Results
First PageMeta Content
Myeloid leukemia / Myelodysplastic syndrome / Syndromes / Genetics / Orphan drugs / Acute myeloid leukemia / MECOM / Fanconi anemia / Arsenic trioxide / Medicine / Oncology / Chemistry


Summer 2004 • Volume 9, Issue 2 THE MDS NEWS The Newsletter of The Myelodysplastic Syndromes Foundation From the Guest
Add to Reading List

Document Date: 2013-09-19 18:47:59

Open Document

File Size: 429,23 KB

Share Result on Facebook

City

San Francisco / Nagasaki / Smith / Marseille / Geneva / Hiroshima / New Orleans / Voytek / Los Angeles / /

Company

Celgene / Pharmion Corporation / Case / HP / International Working Group / /

Continent

Europe / /

Country

Switzerland / France / Scotland / United States / /

Event

FDA Phase / Product Recall / Product Issues / /

Facility

MD University of Dundee Medical School Dundee / Luke’s Medical Center / Research Institute / University of California/Norris Cancer Center / National Cancer Institute / /

IndustryTerm

therapy for this disease / treatment of relapsed or refractory acute prolmyelocytic leukemia / injectable solution / healthcare professionals / chemicals / treatment of highly curable diseases / treatment of myelodysplastic syndrome / classification systems / /

MedicalCondition

low-risk and high-risk disease / myelodysplastic syndrome / ankylosing spondylitis / APL differentiation syndrome / Refractory Anemia / pulmonary edema / Diarrhea / Leukemia / tumor / true hypersensitivity / Cancer / chronic myelomonocytic leukemia / chronic / neutropenia / Fever / myelodysplasia / diseases / generalized rash / rash / acute myeloid leukemia / disorders / hematologic malignancy / very serious and life-threatening disease / TB / leukopenia / myelodysplastic syndromes / bone marrow fibrosis / drug-related nausea / Nausea / thrombocytopenia / severe nausea / Aplastic Anemia / MS / pruritus / individual’s disease / cancers / highly curable diseases / disease / Dyspnea / RAEB / rare disease / vomiting requiring prophylactic antiemetics / Pain / Hodgkin’s lymphoma / refractory acute prolmyelocytic leukemia / syndrome / categorising an individual’s disease / /

MedicalTreatment

platelet transfusions / radiotherapy / radiation / immunosuppression / red blood cell transfusions / intravenous infusion / drug therapy / /

MusicGroup

Nausea / /

Organization

University of California / Luke’s Medical Center in Chicago / American Society of Clinical Oncology in New Orleans / University of Dundee Medical School Dundee / Research Institute in Tampa / World Health Organisation / MDS / European Commission / FDA / American Society of Pediatric Hematology/Oncology / H. Lee Moffitt Cancer Center / European Union / European Hematology Association / National Cancer Institute / MDS Foundation / Congress / Foundation MDS Board of Directors / U.S. Food and Drug Administration / Institut Paoli-Calmettes / /

Person

Susan Hogan / Dan Douer / Patrick J. Mahaffy / Norbert Vey / Nancy Mrzljak / Alan List / Azra Raza / Kathy Heptinstall / /

/

Position

president and chief executive officer / Major / Editor / Principal Investigator / lead investigator / candidate therapies / /

Product

promethazine / Vidaza / chlorzoxazone / prochlorperazine / bias / TRISENOX / TRISENOX® (arsenic trioxide) injection / TRISENOX ® / Approved Drug / treatment / First Drug / MDS / /

ProvinceOrState

Prince Edward Island / Louisiana / Montana / California / Florida / /

PublishedMedium

Cancer Research / /

SportsEvent

Inaugural Charity Golf Tournament / Bone Marrow Donor MDS Foundation Golf Tournament / /

TVShow

Healthy Body / Healthy Mind / /

Technology

radiation / apoptosis / gene expression / /

URL

www.pharmion.com / /

SocialTag